Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall drug_companyScios, Inc. is a Fremont California based Pharmaceutical Corporation. In 2003 Scios became a subsidiary of drug giant Johnson & Johnson . In 2001 Scios announced the launch of their primary product Natrecor (nesiritide) used in treating heart disease and heart failure. Natrecor is also used in treating some inflammatory diseases and some forms of cancer.
Natrecor (nesiritide) – The FDA approved Natrecor in 2001 for treating acute congestive heart failure and shortness of breath. Natrecor was only FDA approved for use in emergency rooms and other life-threatening cases. The drug costs $500 a dose. In 2005 allegations about Scios marketing Natrecor for “off-label” uses arose. Off-label means the drug was used for non-FDA approved reasons.
While it generally is not against the law to use an approved drug for off-label reasons, it is illegal for drug companies to market to those specific off-label purposes. Natrecor has many cheaper alternatives, which run about $10 a dose. It is highly unethical for medical professionals to “push” Natrecor on non-emergency cases, especially when other drugs are widely available. It is also illegal for the drug company to market the drug for those uses.
If you have experienced side effects, please contact a Natrecor lawyer to learn more about your legal rights.
Two men filed personal injury lawsuits against Pfizer, alleging that the pharmaceutical giant concealed serious health risks associated with its popular cholesterol drug Lipitor.
The lawsuits accuse Pfizer of promoting Lipitor as a safe drug w...
A pseudoephedrine lawsuit filed in Oklahoma is being closely watched around the country because it is the first of its kind.
The suit is being filed by the widow of an Oklahoma State Trooper who was killed by an illegal drug dealer and manufac...
Drug giant Eli Lilly and Co., manufacturer of such blockbuster drugs as Prozac and Zyprexa have pled guilty to a misdemeanor charge as a part of a legal settlement with the US government. The US charged that Eli Lilly had been marketing its drug Evista...